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Abstract: 
Background: A large variety of foregut symptoms can occur in patients with 
Gastroesophageal Reflux Disease (GERD), which can overlap with other disorders 
such as somatoform disorders and dyspepsia. Due to unclear diagnostic situations, 
these patients are often not adequately managed. Purpose of this study is the 
evaluation of patients with foregut symptoms, referred for possible antireflux surgery, 
regarding their relationship with GERD and somatization tendencies  based on 
control data from an unselected population.  
Methods: Symptom evaluation and Somatization screening were initiated both in 
volunteers and in patients with foregut symptoms and GERD. Unselected volunteers 
from a village population were also evaluated by symptom analysis and for 
somatisation tendency. In addition, patients with foregut symptoms were diagnosed 
for GERD and symptom analysis and psycho-diagnostic evaluation was performed.  
Results: There is no major significant difference in the symptom-spectrum in patients 
with foregut symptoms, whether they have a proven pathologic acid exposure from 
GERD or not. The probability for the risk of somatization was 5,6 % in the unselected 
population of non-patient volunteers (n=267). In patients with foregut symptoms 
(n=750), the probability for the presence of somatoform tendencies was 
approximately 20 %, independent whether these patients had a documented GERD 
or a normal esophageal acid exposure, implicating further diagnostic work-up for the 
selection of patients for antireflux surgery. 
Conclusion: There is a remarkable symptom load and variety in patients with GERD, 
in patients with foregut symptoms and in an unselected population of volunteers. 
There is no difference in the risk for somatization between patients with foregut 
symptoms and those with documented GERD. Therapeutic decision making 
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The selection of patients for antireflux surgery is as important as a good operative 
technique in reaching a satisfying therapeutic outcome for the patients. The variety of 
symptoms in patients with possible gastroesophageal reflux disease is substantial 
and have to be analysed prior to considering surgery (1-7). Especially the overlap to 
other diseases and in particular to functional disorders bears the risk of wrong 
diagnoses and misinterpretations (2,4,6,8-13). In general, foregut symptoms such as 
epigastric pain, nausea, vomiting, belching, regurgitation, epigastric and/or 
retrosternal burning, swallowing discomfort or even respiratory symptoms such as  
hoarseness, chronic cough, pain in the throat, globus, pharyngeal, mouth and tongue 
burning can be related to Gastroesophageal Reflux Disease (GERD) as well as to 
several other diseases and pathologic conditions, which can be  difficult to 
differentiate (1-13). A substantial part of these patients have symptoms from 
dyspepsia and  somatoform disorders (4,8-13).  
GERD has a multifactorial pathophysiologic background and its clinical presentation 
shows a large variety of different symptoms including heartburn, regurgitation, 
epigastric pain, retrosternal pressure and pain, pharyngeal burning, hoarseness, 
chronic cough, nausea, vomiting and dysphagia (1,3,4,5,7,14). As shown in the past, 
heartburn and acid regurgitation are highly specific for GERD, when these are chief 
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complaints of the patients (1,2,4,6,7,). However, these symptoms can show a broad 
overlap with other disorders such as functional dyspepsia, irritable bowel syndrome 
and somatoform disorders (8-23).     
Severe GERD can be objectified by endoscopy and by functional studies such as  
Impedance-pH-monitoring (4,7,24,25). But it remains a diagnostic dilemma in 
patients with borderline objective diagnostic findings in association with a large 
variety of unspecific foregut symptoms. 
 
Somatization describes a situation, where in a given patient/person somatic 
complaints are present, which cannot be explained by pathophysiological and/or 
measurable findings (4,9,10,26-31). Psychodiagnostic instruments are helpful in 
order to clarify the clinical situation and establish a diagnosis. Several tests are 
available to evaluate patients/persons with a suspicion of having a somatoform 
disorder (27-33).  Very often these patients have comorbid symptoms of depression 
and anxiety (33,34). In addition, somatoform disorders and anxiety can hamper the 
clinical assessment of patients (35,36).  
Due to this unclear diagnostic situation, these patients are often not adequately 
managed, since in many patients symptomatic therapy is started without further 
verification of the diagnostic background (37-39). Furthermore, some patients receive 
insufficient drug therapy or inadequate life style advise for years, and sometimes 
even worse, they are referred to unjustified surgical therapy, after a long, refractory 
drug therapy.  
 
Even more demanding for the diagnostic situation, the quality of life can be severely 
impaired in these patients and consequently the subjective experience of suffering 
can be demanding (7,40,41,42). Thus, there is a need for clearly defined criteria for 
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therapeutic decision making based on sound reasoning and objective data. 
Especially prior to gastric or antireflux surgery, a clear diagnostic picture with proven 
symptom-correlation to the underlying disease is mandatory. However, little is known 
about the relationship between GERD and somatoform tendencies.  
 
Therefore, the purpose of this study is the evaluation of patients with a large variety 
of foregut symptoms, referred to a specialized surgical unit for possible laparoscopic 
antireflux surgery, regarding their pathophysiologic background and their relationship 






In this trial, the first step was a basic evaluation of the chosen instruments for 
symptom evaluation in a large unselected population of non-patient volunteers.  
Symptom evaluation and Somatization screening were initiated both in volunteers 
and in patients with foregut symptoms in order to determine the possible differences. 
 
Unselected population of non-patient volunteers (Normal control group) 
For comparison, an unselected population of two villages was investigated, using 
questionnaires to determine the presence and the variety of their symptoms. In 
addition, a validated screening instrument for somatoform tendencies was applied. 
For that purpose, the inhabitants of the villages were informed 3 weeks prior to the 
questionnaire about the project. Then the instruments for the assessment of 
symptoms and the evaluation of somatoform disorders (27-31) were distributed. Two 
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days later the questionnaires were recollected and then evaluated. Inhabitants, who 
were known to be currently under medical treatment or who were seeking medical 
help, were excluded from the analysis. 
 
Patients 
Patients with foregut symptoms and heartburn, referred to a specialized referral 
center of gastrointestinal functional disease during a period of 4 years, were asked 
for their permission and were subsequently registered in the study, as permitted by 
our Institutional Review Board. They entered a defined prospective protocol of 
assessment and investigations. All patients received standardized questionnaires to 
assess all presenting symptoms, a validated screening test for somatoform disorders 
(27-31) similar to the normal control group.   
Furthermore, the protocol consisted of documentation of their medical history, 
physical examination, upper gastrointestinal endoscopy, standard esophageal 
manometry, 24h-pH–monitoring, and other selectively used investigations such as 
24h-bilirubine monitoring, gastric emptying scintigraphy and radiographic barium 
studies in order to determine the presence of GERD or other diseases, as described 
earlier (1,3,7).  
 
Diagnostic Investigations: 
Assessment of the variety of symptoms was performed by using the symptom-list 
as integrated in the instrument for the evaluation of somatoform disorders as 
established and validated by Rief (27-31). The SOMS-Instrument was chosen, 
because it provides an extended list of symptoms, which serves the purposes of this 
study best, as it allows to screen for a general symptom load, which provides a 
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sufficient number of non-gastrointestinal symptoms, to screen for a general symptom 
load in patients with a suspected or known gastrointestinal disorder.  
 
The SOMS-instrument as “screening test for somatoform disorders” has been 
established and validated a few years ago (27-31). Assessment for the presence of 
somatoform tendencies is performed by using this established instrument in the 
unselected healthy population and in all patients. The instrument SOMS (screening 
test for somatoform disorders) consists of 68 items, basically assessing the presence 
of the full variety of possible symptoms of the test-person.  
In patients with somatoform disorders, some of these symptoms are quite frequently 
present (27,28). The instrument covers somatic symptoms that can occur in these 
patients with somatoform disorders without a clear physical explanation nor prove of 
explainable somatic changes. This questionnaire has extensively been validated and 
several methods of analysis are available (27-31).  
 
 For the purpose of this study, the authors have chosen the analysis of the presence 
of symptoms and the presence of somatoform tendencies, using 53 items, which are 
basically a list of 53 symptoms (Table 1). This symptom list is easy to apply for the 
investigated individuals. The symptom-list can serve as basis for the determination of 
all symptoms. Second, by counting the number of symptoms, present in a given 
patient without an explanation of the underlying cause, one can determine the 
Somatoform Symptom Index (SSI). The latter represents the level of probability for 
the presence of somatoform disorder in a given patient (27). This analysis is 
documented in the original manual and shows for normal values a SSI of 5,1. In the 
original manual (SOMS: Screening für Somatoforme Störungen) by Rief, the 
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borderline value towards 99 percentile probability for the presence of somatoform 
disorders is a SSI of 17 symptoms (27). 
 
All patients underwent upper gastrointestinal endoscopy, esophageal manometry, 
and esophageal 24-h-pH-monitoring. All data were gathered and documented 
prospectively. During endoscopy, the severity of esophagitis was graded according 
to the classification of Savary-Miller and the present size of the hiatus hernia was 
measured.  
Standard esophageal manometry was carried out using an 8-lumen, water-
perfused manometry catheter on the reclining, fasting patient. The position, pressure, 
and length of the lower esophageal sphincter were determined with the pull-through 
manometry, using these measurements for the correct positioning of the pH-probes 
5cm above the upper boarder of the lower esophageal sphincter.    
24h-pH-monitoring was applied in standard technique using for analysis the 
DeMeester-reflux-score criteria (1). This implemented a borderline between 
physiologic and pathologic esophageal acid exposure, if the score reached a value of 
14,7. Seven days prior to the examination all medications affecting motility and acid 
suppression were stopped.   
 
Analyses 
Different analyses were performed on the generated data. A first analysis was made 
by creating an overview on the presence and variety of different symptoms in the 
unselected control population (symptom-analysis 1), in all patients with foregut 
symptoms, separated in those without pathologic reflux (symptom-analysis 2) as well 
as in patients with documented GERD (symptom-analysis 3).  
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Secondly, the probability for the presence of somatoform tendencies was evaluated 
in the unselected control population, in the patient-group with foregut symptoms and 
in the documented GERD-patients in order to determine the differences. 
 
Since the size of the investigated populations were rather large, the  students T-test 
was used for the simple group comparisons. If multiple comparisons were performed 
such as in the analysis of symptoms, alpha-level was adjusted accordingly (for n=53 
items in the SOMS manual adjusted p=0.00094). For the comparison of the number 
of patients with positive and negative DeMeester score compared to an SSI≤17 or 
>17 (contingency table) a Chi-square test was conducted. All analyses were carried 





Characteristics of Control group: 
The unselected control-group consisted of 267 healthy inhabitants of two villages. 
There were 127 males and 140 females.  The mean age was 44 years (Standard 




In a 4 year period 750 patients with foregut symptoms and heartburn were 
prospectively included in this study. Patients had a mean age of 49 years (16-89). 
There were 305 females and 445 males. The prospectively documented data showed 
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at time of evaluation for this study a partial lack of data in 99 data-sets, leaving 651 
complete patient data-sets (foregut-symptom group) for detailed analysis. 
 
The patients of the foregut-symptom group (n=651) had  a mean age of 49 years (18-
86). There were 397 males and 254 females. Current presence of esophagitis was 
confirmed  by endoscopy  in 208 patients (32 %). The results of 24h-pH-monitoring 
showed a positive DeMeester-reflux Score in 389 patients (59,8%), indicating a 
patient-group with proven GERD.  Esophagitis was present in 196 of the 389 patients 
(50,4 %) with documented pathologic acid exposure in the esophagus.  
 
Unselected population of non-patient volunteers: 
Figure 1 demonstrates the presence of symptoms in the control group. The 
volunteers showed a remarkable symptom load with a large variety such as 
headache, repetitive pain in joints, in the back, in arms and legs in 30 to 54 %. In 
addition, 15 - 20% of persons in the unselected control group had complaints about 
unspecific symptoms such as fullness, nausea, food intolerance, belly pain, chest 
pain, excessive fatigue and other unspecific troublesome body sensations.  
 
Comparison between patients and the control group: 
The classic foregut symptoms such as epigastric pain, belly pain, fullness and 
belching are more frequently present compared to healthy volunteers. Belly pain is 
present in 70 % of patients, fullness in 67%, belching in 72 %, hick-ups and burning 
in 69%, and food intolerance in 60%. 
The comparison between the symptom presence in unselected volunteers and in 
patients with foregut symptoms demonstrate significant differences for several 
symptoms. The most important differences are shown in Table 2. 
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Comparison of symptom distribution in relation to esophageal acid exposure: 
Figure 2 demonstrates the difference in symptoms between patients with a positive 
and those with a negative 24h-pH-monitoring test, the latter indicating either a rather 
mild form of reflux problem or a functional dyspepsia. There was no difference in 
symptom presence for a number of “reflux-like” symptoms such as belching, burning 
and hick-ups. There were marginal significant differences for swallowing problems 
and epigastric pain/belly pain. 
 
The probability for the presence of somatoform disorders in health and GERD:  
In the unselected population of non-patient volunteers (n=267), the Somatoform 
Symptom Index (SSI) was 6,4 (Standard Deviation: 5,7) (Median: 5 (0-35)), as shown 
in Figure 3. The borderline value between normal range for the number of presenting 
symptoms (total 53 items of SOMS) and the abnormal pathologic number of 
presenting symptoms was calculated and determined as SSI=17,8.  
Among the healthy individuals 15 out of 267 individuals had a SSI > 17, thus 
indicating that 5,6 % of this population show a risk for a somatoform tendency, if they 
did not have an undiagnosed disorder. This value confirms the original data 
published in the SOMS-manual by Rief (27), in which they have listed normal 
percentage values for different percentiles. The value SSI >17 reflects a 99% 
probability of the presence of somatoform disorder. In the unselected population of 
non-patient volunteers, included in the study, the percentage of patients with 
somatoform tendency (5,7 %) was similar to the norm population in the SOMS-
manual. 
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Figure 3 demonstrates the SSI for the different groups of analyses. In patients with 
foregut symptoms (n=651), the mean SSI was 11,6 (Median:11 (0-37)). This was 
significantly higher than in the control group, 6,4 versus 11,6 % (p< 0,001). In 
patients with documented GERD (n=389), the mean SSI was calculated with 11,4 
(Median: 11). Patients with foregut symptoms and a normal acid exposure had a 
mean SSI of 11,8 (Median: 11), which was quite similar to those patients with GERD. 
 
The relationship between GERD and possible somatoform tendencies in 
patients with foregut symptoms:   
Figure 4 demonstrates the distribution of individuals with and without somatoform 
tendencies in the different groups. Out of 651 patients with foregut symptoms, n=389 
patients had proven GERD. Of these patients, 76 patients (19,9 %) showed in 
addition a SSI > 17, which would under the exclusion of a given, pertinent 
pathophysiology indicate a risk for a somatoform disorder, compared to 5,6 % in the 
normal control group.  
Figure 5  demonstrates this relationship between the presence of GERD based on 
acid exposure and the SSI.  In patients with a pathologic esophageal acid exposure, 
19,5 % show a positive SSI (SSI >17), while patients with a normal acid exposure 
have in 20,6% a positive SSI. The Chi2 –Test was not significant (p=0,679)). In 
addition, the 12 patients with esophagitis and a normal esophageal acid exposure did 
show a similar relation between SSI-positive and SSI negative individuals in SSI>17. 
This indicates that there was no statistical connection  between acid exposure and a 
measure for somatoform tendencies, the SSI in a group of patients with GERD, and 
thus a high symptom load.  
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In summary, the results of this study show a remarkable variety of symptoms in 
healthy volunteers and in patients seeking help because of their foregut symptoms. 
There is no major significant difference in the symptom-spectrum in patients with 
foregut symptoms, whether they have a proven pathologic acid exposure from GERD 
or not. 
The probability for the risk of somatization as indicated by a SSI > 17 was as high as 
5,6 % in the unselected population of non-patient volunteers. In patients with foregut 
symptoms, the probability for the presence of somatoform tendencies was 
approximately 20 %, independent whether these patients had a documented GERD  
or a normal esophageal acid exposure. Furthermore a high risk for somatization can 






This work was stimulated by the diagnostic dilemma regarding patients with a large 
variety of foregut symptoms, seeking for medical help and possible antireflux surgery 
to receive relief from their symptoms. The vast majority of these patients are usually 
ex juvantibus treated by antisecretory medication. With limited therapeutic success of 
their medication, these patients quite often find their way to antireflux surgery. The 
particular strength of the data presented here are i) the defined prospective protocol 
of assessment and investigations and ii) the unselected control population. Both 
populations were measured with the same questionnaires thus allowing for a direct 
comparison. This is insofar new as it enables a direct comparison between the 
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situation in the GP’s office and the reality of a tertiary specialist care center with 
regard to GERD symptoms and somatoform tendencies. To our knowledge, no such 
data are available to date. 
 
Symptoms, originating in the foregut, can have a large variety, as demonstrated 
again in this study. If the symptom load is high and includes a number of symptoms 
from different systems (e.g. gastrointestinal and cardiovascular), patients may also 
suffer a risk for the presence of a somatoform or, as recently defined, a somatic 
symptom disorder 9,10,23,27,30). 
Symptoms, caused by GERD, can also vary substantially (1,2,4,5,7,14). These 
symptoms can be differentiated in typical symptoms, such as heartburn and/or 
regurgitation (2,4,6,7) and rather unspecific gastrointestinal symptoms are epigastric 
pain, nausea and vomiting, belching and chest pain (2,4,7).  
Heartburn in patients with pathologic acid reflux is present in 72 -99 % (1-3,4,5,6,7, 
14). Heartburn can be also present in 6-20 % of dyspepsia patients (6,12-19,21-23). 
However, there are controversial reports regarding the correlation between functional 
testing and symptoms, which makes precise diagnosis difficult based on symptoms  
(2,4,7,17,20,37-39). However, the presence of heartburn and regurgitation in patients 
with GERD does have a positive prognostic value regarding the outcome of a 
potential antireflux operation (43).  
Regurgitation is also one of the most important symptoms in GERD  with a 
prevalence of 33 - 86% (1,2,3,4,7,44).  Epigastric pain is present in patients with 
foregut symptoms in 70 %, in those with documented pathologic acid reflux in 12 - 67 
%.  The overlap with dyspepsia and somatoform disorders is large (1-20).  
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Extraesophageal symptoms such as cough, hoarsness, globus and breathing 
problems  can be associated with  syndromes such as Reflux cough syndrome  and 
with laryngitis and asthma (4,7,45-52).  
 
In this study, the diagnosis of GERD in the “foregut patients” was established based 
on the traditional diagnostic workup with clinical evaluation, endoscopy and functional 
testing including ph-monitoring to determine the esophageal acid exposure (1,3). This 
was done with intention to verify undoubtedly the presence or absence of the 
disease. One could argue that esophagitis-positive is enough proof of GERD and no 
further diagnostic testing is necessary (6). The diagnostic value of the presence or 
absence or the grading of esophagitis is limited by the unknown effect of 
protonpump-inhibitor therapy, which can not be assessed accurately in such a patient 
population. The authors felt that for the purpose of this study, a clear separation 
criterion was needed, which could be best served by the acid exposure as measured 
by 24h-pH-monitoring. This would allow for a sharp discrimination line between 
physiologic and pathologic acid exposure (1,3,7).  
 
The authors have chosen the SOMS instrument of Rief, because this instrument is 
validated extensively and its applicability is possible in all patients (27-31). The 
SOMS instrument covers a large variety of symptoms, including also physical 
symptoms, which many patients with foregut problems do have. The latter is 
important to have a common pool of symptoms covering the aspect of somatization 
and GERD. For the comparison of the data with GERD-patients the authors wanted 
to include as many symptoms in the total assessment as possible to make sure that 
all possible reflux associated symptoms would be integrated in the analysis. 
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A central criterion for the diagnosis of somatoform disorders has been the exclusion 
of a somatic disorder, that can explain the symptom pattern (27-29,36). However, this 
has been a major challenge in the diagnostics of somatoform disorders, since 
patients can very well have pathological findings, which, however, do not explain the 
extent of their symptom load or the suffering associated with it. Therefore, this 
demand has been substantially weakened in the very recent Diagnostic and 
Statistical Manual of Mental disorders (DSM-5) and the syndrome has recently been 
renamed to “somatic symptom disorder” (36). However, since the data collection and 
the whole rationale of the study is based of the former definition of the DSM IV, the  
terminology of somatoform disorder can be used. 
  
Nonetheless, the current redefinition sheds light on the implicit challenge to establish 
an appropriate procedure with the goal to achieve a good diagnostic process, which 
takes all aspects of the patients suffering into account: the “objective” 
pathophysiological measures, and the subjective suffering associated with the 
symptom load. Thus, the establishment of a precise diagnosis based on symptom 
analysis in patients with foregut symptoms with the aim to differentiate between 
GERD and  functional dyspepsia, while at the same time taking the aspect of 
somatization into account, is challenging (8,16,17,20). 
 
If the symptom load in GERD was exclusively related to pathologic acid exposure, 
then it could have been expected that patients with high symptom load and a 
negative DeMeester score would show a higher risk for somatization. However, this 
was not the case. 
The data suggests that there is no correlation between the symptoms and the 
objective data of esophageal acid exposure as well as the tendency for a somatoform 
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disorder, which irritates on first sight. However, this was shown in the statistical 
comparison with parametric tests  using large groups. In addition, also non-
parametric tests (Spearman-Rho) were performed indicating that both showed no 
significant correlation. Considering the size of the volunteer population and the 
patient population, it can be concluded that indeed the presence of symptoms does 
not correlate to the objective functional data. 
 
In conclusion, these findings do imply that in the case of GERD, somatoform 
tendencies as indicated by a SSI > 17 can well be associated with pathological reflux. 
These findings emphasize the usefulness of the redefinition of the concept of 
somatoform disorders, as expressed in the DSM-5 (27,36). Indirectly, this present 
study and its control group reproduces and thus confirms the original data published 
in the SOMS-manual by Rief, in which they have listed normal percentage values for 
different percentiles (27). The value of more than 17 symptoms for the SSI reflects a 
99% probability of the presence of somatoform disorder in the original validation, 
which corresponds exactly to the result of the control population in this study.  
 
A number of studies have been performed with similar intention (10,32,36,37,38,53-
56). Other instruments are the symptom-check-list SCL-90-R and the Hypochondrie- 
Scale MMPI, which evaluate fewer symptoms and are therefore more restricted 
(10,27,53,54). Another instrument is the “Othmer and de Souza Screening Test” for 
somatoform disorders (55,56,57). The latter has been also criticized  for the limited 
number of symptoms.  With the SCAN-Test (Schedules for Clinical Assessment in 
Neuropsychiatry) 19% of patients within an investigated population was detected with 
signs for somatoform disorders, which reflects a similar portion of patients as in our 
current study population (57). 
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In a study from Australia, 340 family doctors were involved, using the Kessler 
Psychological Distress Scale, the Whiteley Index and the 15-item Patient Health 
Questionaire (PHQ-15) on their patients (10). In 10507 patients, 18,5 % were 
identified as “somatizer”, thus suffering from somatoform tendencies.  
 
Again, it is quite interesting that the portion of patients with signs of somatoform 
disorders, is reported in different studies at the level around 20% in several patient 
populations with different disease entities. As detected in this study with GERD 
patients, the portion of patients with signs of somatization  was also around 20 %.  
 
Conclusions: 
In conclusion, the results of this study show a number important facts: 
There is a remarkable symptom load and variety in patients with foregut symptoms 
and more specific in patients with documented GERD. The portion of patients, who 
are at risk for a somatisation disorder was  around 20 %. There is no difference in the 
risk for somatization between patients with foregut symptoms and those with 
documented GERD. 
 There is also a substantial variety of symptoms in an unselected population of non-
patient volunteers. A reasonably high proportion of these study participants (5,6 %) 
would be classified as being at risk for a somatoform disorder, if they did not suffer 
from a confirmed somatic disease.  
 
Based on these findings, our study has important clinical implications for the future, 
which can be concluded as follows: Symptoms are not a reliable guide in these 
functional disorders to verify the diagnosis alone, especially in GERD. Functional 
testing is essential for a precise diagnosis or exclusion of GERD and subsequent 
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therapeutic decision making. If in the diagnostic process, a risk for a somatoform 
symptom disorder is perceived, a further clinical psycho-diagnostic evaluation is 
recommended. An accurate process of therapeutic decision making especially prior 
to antireflux surgery in all patients with multiple and complex foregut symptoms, 
requires not only a thorough investigation of the somatic pathophysiology, but in 
addition an awareness of the mental and emotional challenges, many patients with a 
high symptom load have. These aspects are of utter importance for the clinical 
prospects of the individual patient and should also have an impact on patient 
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Legends of Figures: 
Figure 1: Distribution of symptoms (in %) in healthy individuals 
 
Figure 2: Comparison of symptom-distribution (in %) of patients with foregut 
symptoms between those patients with pathologic esophageal acid exposure (white) 
versus those with normal acid exposure (black). 
 
Figure 3: Overview on the Somatoform Symptom Index (SSI) of healthy individuals 
and patients with foregut symptoms (black columns), as well as further subdivided in 
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the grey columns (right) in those with and those without pathologic acid exposure as 
criterion for the presence of GERD. 
 
Figure 4: Comparison of the presence of somatoform tendencies (SSI > 17) in 
healthy individuals (5,6%) compared to patients with foregut symptoms (19,9%), 
demonstrated in 267 unselected healthy volunteers and 651  patients with foregut 
symptoms. 
 
Figure 5: Comparison of the presence of somatoform tendencies (SSI > 17) in 
patients without (20,6%) and with pathologic acid exposure as criterion of the 
presence of GERD (19,5%). 
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Figure 5: 
 
 
 
 
 
